Literature DB >> 9862729

Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.

B Salh1, R Wagey, A Marotta, J S Tao, S Pelech.   

Abstract

Phosphatidylinositol 3-kinase (PI 3-kinase) and protein kinase B are critical players in cell proliferation and survival. Their downstream effector protein kinase, p70 S6 kinase, has an established role in protein translation. The mechanism by which bacterial LPS induces production of nitric oxide (NO) in murine macrophages is incompletely understood, and a role for PI 3-kinase/p70 S6 kinase pathway had not been previously investigated. In this study we demonstrate that LPS induced a fivefold activation of p70 S6 kinase and a twofold stimulation of PI 3-kinase. Pretreatment of Raw 264.7 cells with either rapamycin or Ly290042 completely blocked LPS-induced activation of p70 S6 kinase. Protein kinase B was also activated (twofold) by LPS and was only minimally affected by these inhibitors. PI 3-kinase activity was inhibited by both Ly294002 and wortmannin. The effects on NO production by these agents were strikingly different. While both rapamycin and Ly294002 resulted in almost complete inhibition of NO production, wortmannin was ineffective. Surprisingly, none of the inhibitors reduced the production of the inducible nitric oxide synthase protein (iNOS) as determined by immunoprecipitation. In vivo labeling studies revealed that the iNOS protein was phosphorylated in concordance with the production of NO. We conclude that LPS-mediated NO production occurs via a PI 3-kinase-independent, but FKBP12-rapamycin-associated protein-dependent, pathway in RAW cells by a mechanism probably involving phosphorylation of iNOS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862729

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Redox regulation of PI 3-kinase signalling via inactivation of PTEN.

Authors:  Nick R Leslie; Deborah Bennett; Yvonne E Lindsay; Hazel Stewart; Alex Gray; C Peter Downes
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 2.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

3.  Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.

Authors:  Nobuki Ichikawa; Kenichiro Yamashita; Tohru Funakoshi; Shin Ichihara; Moto Fukai; Masaomi Ogura; Nozomi Kobayashi; Masaaki Zaitsu; Tadashi Yoshida; Susumu Shibasaki; Yasuyuki Koshizuka; Yusuke Tsunetoshi; Masanori Sato; Takahiro Einama; Michitaka Ozaki; Kazuo Umezawa; Tomomi Suzuki; Satoru Todo
Journal:  Inflamm Res       Date:  2015-12-18       Impact factor: 4.575

4.  Mycobacterial induction of autophagy varies by species and occurs independently of mammalian target of rapamycin inhibition.

Authors:  Alfred J Zullo; Sunhee Lee
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

5.  Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis.

Authors:  Ralph A Zirngibl; Yotis Senis; Peter A Greer
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets.

Authors:  Tapani Ronni; Vishal Agarwal; Michael Haykinson; Margaret E Haberland; Genhong Cheng; Stephen T Smale
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.

Authors:  Christelle Mérial-Kieny; Michel Lonchampt; Francis Cogé; Patrick Verwaerde; Jean-Pierre Galizzi; Jean A Boutin; Max Lafontan; Nigel Levens; Jean Galitzky; Michel Félétou
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

8.  Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin.

Authors:  Angeliki Xagorari; Charis Roussos; Andreas Papapetropoulos
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

9.  CaMKIα regulates AMP kinase-dependent, TORC-1-independent autophagy during lipopolysaccharide-induced acute lung neutrophilic inflammation.

Authors:  Lanping Guo; Jennifer L Stripay; Xianghong Zhang; Richard D Collage; Mei Hulver; Evie H Carchman; Gina M Howell; Brian S Zuckerbraun; Janet S Lee; Matthew R Rosengart
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

Review 10.  Akt in the pathogenesis of COPD.

Authors:  Steven Bozinovski; Ross Vlahos; Michelle Hansen; Ken Liu; Gary P Anderson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.